AstraZeneca PLC (ZEG.DE)
XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 221.69B |
| Enterprise Value | 246.27B |
| Trailing P/E | 38.30 |
| Forward P/E | 18.32 |
| PEG Ratio (5 yr expected) | 0.96 |
| Price/Sales (ttm) | 5.09 |
| Price/Book (mrq) | 6.42 |
| Enterprise Value/Revenue | 5.58 |
| Enterprise Value/EBITDA | 19.31 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.15 |
| 52-Week Change 3 | 21.36% |
| S&P500 52-Week Change 3 | 25.87% |
| 52 Week High 3 | 150.60 |
| 52 Week Low 3 | 112.35 |
| 50-Day Moving Average 3 | 144.50 |
| 200-Day Moving Average 3 | 127.82 |
Share Statistics
| Avg Vol (3 month) 3 | 31.98k |
| Avg Vol (10 day) 3 | 6.81k |
| Shares Outstanding 5 | 1.55B |
| Implied Shares Outstanding 6 | 1.55B |
| Float 8 | 1.54B |
| % Held by Insiders 1 | 0.04% |
| % Held by Institutions 1 | 50.03% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 2.65 |
| Forward Annual Dividend Yield 4 | 1.84% |
| Trailing Annual Dividend Rate 3 | 2.90 |
| Trailing Annual Dividend Yield 3 | 2.02% |
| 5 Year Average Dividend Yield 4 | 2.39 |
| Payout Ratio 4 | 71.30% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Feb 22, 2024 |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 13.30% |
| Operating Margin (ttm) | 26.11% |
Management Effectiveness
| Return on Assets (ttm) | 7.04% |
| Return on Equity (ttm) | 17.29% |
Income Statement
| Revenue (ttm) | 47.61B |
| Revenue Per Share (ttm) | 30.74 |
| Quarterly Revenue Growth (yoy) | 16.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 15.8B |
| Net Income Avi to Common (ttm) | 6.33B |
| Diluted EPS (ttm) | 3.75 |
| Quarterly Earnings Growth (yoy) | 20.90% |
Balance Sheet
| Total Cash (mrq) | 8.02B |
| Total Cash Per Share (mrq) | 5.18 |
| Total Debt (mrq) | 34.69B |
| Total Debt/Equity (mrq) | 92.51% |
| Current Ratio (mrq) | 0.89 |
| Book Value Per Share (mrq) | 24.17 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 9.7B |
| Levered Free Cash Flow (ttm) | 8.68B |
© 2024 Yahoo. All rights reserved.